Literature DB >> 2292078

Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal women.

D Hartwell1, B J Riis, C Christiansen.   

Abstract

We studied 20 healthy premenopausal women aged 36.5 +/- 4.0 years (mean +/- 1 SD), 123 healthy postmenopausal women aged 50.0 +/- 2.4 years, and 103 postmenopausal women aged 65.1 +/- 5.6 years with symptomatic osteoporosis (forearm and spinal fracture). Serum levels of vitamin D metabolites [25(OH)D, 24,25(OH)2D3, and 1,25-(OH)2D] were compared with (1) bone mass in the forearm (single photon absorptiometry) and in the spine (dual photon absorptiometry); (2) biochemical indices of bone formation (serum alkaline phosphatase, plasma bone Gla protein), and bone resorption (fasting urinary hydroxyproline); and (3) other biochemical estimates of calcium metabolism (serum calcium, serum phosphate, 24-hour urinary calcium, intestinal absorption of calcium). The present study revealed no difference in any of the vitamin D metabolites between the premenopausal women, the healthy postmenopausal women and the osteoporotic women as a group. The concentrations of 1,25(OH)2D and 25(OH)D were significantly lower in patients with spinal fracture than in those with forearm fracture. In the early postmenopausal women serum 1,25(OH)D was related to forearm bone mass (r = -0.20; P less than 0.05), intestinal calcium absorption (r = 0.18; P less than 0.05), and 24-hour urinary calcium (r = 0.21; P less than 0.05); serum 25(OH)D was related to spinal bone mass (r = 0.23; P less than 0.01). In the osteoporotic women, serum vitamin D metabolites were not related to bone mass, but 1,25(OH)2D was related to bone Gla protein (r = 0.33; P less than 0.001), serum phosphate (r = -0.27; P less than 0.01), and 24-hour urinary calcium (r = 0.43; P less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2292078     DOI: 10.1007/bf02555883

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  34 in total

1.  Nasal calcitonin for treatment of established osteoporosis.

Authors:  K Overgaard; B J Riis; C Christiansen; J Pødenphant; J S Johansen
Journal:  Clin Endocrinol (Oxf)       Date:  1989-04       Impact factor: 3.478

2.  The influence of age on bone mineral regulating hormones.

Authors:  S Epstein; G Bryce; J W Hinman; O N Miller; B L Riggs; S L Hui; C C Johnston
Journal:  Bone       Date:  1986       Impact factor: 4.398

3.  Rates of bone loss in normal women: evidence of accelerated trabecular bone loss after the menopause.

Authors:  L Nilas; C Christiansen
Journal:  Eur J Clin Invest       Date:  1988-10       Impact factor: 4.686

4.  Prediction of rapid bone loss in postmenopausal women.

Authors:  C Christiansen; B J Riis; P Rødbro
Journal:  Lancet       Date:  1987-05-16       Impact factor: 79.321

5.  Measurement of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in clinical settings.

Authors:  L Hummer; L Tjellesen; H Rickers; C Christiansen
Journal:  Scand J Clin Lab Invest       Date:  1984-11       Impact factor: 1.713

6.  An easy and reliable method for determination of urinary hydroxyproline.

Authors:  J Pødenphant; N E Larsen; C Christiansen
Journal:  Clin Chim Acta       Date:  1984-09-15       Impact factor: 3.786

7.  Changes in vitamin D metabolism during natural and medical menopause.

Authors:  D Hartwell; B J Riis; C Christiansen
Journal:  J Clin Endocrinol Metab       Date:  1990-07       Impact factor: 5.958

8.  Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.

Authors:  G F Jensen; C Christiansen; I Transbøl
Journal:  Clin Endocrinol (Oxf)       Date:  1982-05       Impact factor: 3.478

9.  Osteomalacia in fractures of the proximal femur.

Authors:  V Hoikka; E M Alhava; K Savolainen; M Parviainen
Journal:  Acta Orthop Scand       Date:  1982-04

10.  Comparisons between two receptor assays for 1,25-dihydroxyvitamin D.

Authors:  D Hartwell; C Christiansen
Journal:  Scand J Clin Lab Invest       Date:  1988-04       Impact factor: 1.713

View more
  2 in total

1.  Calciotropic hormones in elderly people with and without hip fracture.

Authors:  C L Benhamou; D Tourliere; J B Gauvain; G Picaper; M Audran; P Jallet
Journal:  Osteoporos Int       Date:  1995-03       Impact factor: 4.507

2.  Vitamin D intake in mid-pregnancy and child allergic disease - a prospective study in 44,825 Danish mother-child pairs.

Authors:  Ekaterina Maslova; Susanne Hansen; Camilla B Jensen; Andrew L Thorne-Lyman; Marin Strøm; Sjurdur F Olsen
Journal:  BMC Pregnancy Childbirth       Date:  2013-10-31       Impact factor: 3.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.